File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Blocking the PI3K/AKT pathway can impair metastasis of esophageal cancer
| Title | Blocking the PI3K/AKT pathway can impair metastasis of esophageal cancer |
|---|---|
| Authors | |
| Issue Date | 2014 |
| Publisher | World Cancer Congress. The Conference program's website is located at http://wcc-2014.p.asnevents.com.au/tracks/653 |
| Citation | The 2014 World Cancer Congress (WCC), Melbourne, Australia, 3-6 December 2014, abstract 942 How to Cite? |
| Abstract | BACKGROUND: Esophageal cancer (EC) is an aggressive malignancy with increasing incidence and poor outcome (1). New therapeutic strategies are urgently required. The phosphatidylinositol 3-kinase (PI3K)/AKT signal pathway has been documented as a central hub for the malignant behaviors of cancer cells (2). However, the functional role and therapeutic effect of PI3K/AKT inhibitors in esophageal cancer metastasis is underappreciated. AIM: We aim to study the clinical significance of PI3K/AKT signaling pathway in EC metastasis and evaluate the therapeutic effect ... |
| Description | E-posters: 6.5 Scientific Study - Diagnosis/Treatment: no. 942 |
| Persistent Identifier | http://hdl.handle.net/10722/207780 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Xu, W | - |
| dc.contributor.author | Li, B | - |
| dc.contributor.author | Li, YY | - |
| dc.contributor.author | Tsao, SW | - |
| dc.contributor.author | Cheung, ALM | - |
| dc.date.accessioned | 2015-01-19T10:41:19Z | - |
| dc.date.available | 2015-01-19T10:41:19Z | - |
| dc.date.issued | 2014 | - |
| dc.identifier.citation | The 2014 World Cancer Congress (WCC), Melbourne, Australia, 3-6 December 2014, abstract 942 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/207780 | - |
| dc.description | E-posters: 6.5 Scientific Study - Diagnosis/Treatment: no. 942 | - |
| dc.description.abstract | BACKGROUND: Esophageal cancer (EC) is an aggressive malignancy with increasing incidence and poor outcome (1). New therapeutic strategies are urgently required. The phosphatidylinositol 3-kinase (PI3K)/AKT signal pathway has been documented as a central hub for the malignant behaviors of cancer cells (2). However, the functional role and therapeutic effect of PI3K/AKT inhibitors in esophageal cancer metastasis is underappreciated. AIM: We aim to study the clinical significance of PI3K/AKT signaling pathway in EC metastasis and evaluate the therapeutic effect ... | - |
| dc.language | eng | - |
| dc.publisher | World Cancer Congress. The Conference program's website is located at http://wcc-2014.p.asnevents.com.au/tracks/653 | - |
| dc.relation.ispartof | World Cancer Congress, WCC 2014 | - |
| dc.title | Blocking the PI3K/AKT pathway can impair metastasis of esophageal cancer | - |
| dc.type | Conference_Paper | - |
| dc.identifier.email | Li, B: libinhku@hkucc.hku.hk | - |
| dc.identifier.email | Li, YY: yyli@hku.hk | - |
| dc.identifier.email | Tsao, SW: gswtsao@hku.hk | - |
| dc.identifier.email | Cheung, ALM: lmcheung@hku.hk | - |
| dc.identifier.authority | Tsao, SW=rp00399 | - |
| dc.identifier.authority | Cheung, ALM=rp00332 | - |
| dc.description.nature | postprint | - |
| dc.identifier.hkuros | 242209 | - |
| dc.publisher.place | Australia | - |